A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer PeerView Oncology 1:25:22 1 year ago 2 273 Скачать Далее
Clinical outcomes in women with metastatic HER2-low breast cancer in the real world VJOncology 1:17 2 years ago 191 Скачать Далее
Questions remaining in the field of HER2-low breast cancer VJOncology 1:33 1 year ago 531 Скачать Далее
The evolution of HER2-low breast cancer from primary to recurrence VJOncology 0:45 1 year ago 159 Скачать Далее
Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in Review Total Health | Oncology 2:06 1 year ago 92 Скачать Далее
DESTINY-Breast04: practice-changing results for HER2-low breast cancer VJOncology 2:01 2 years ago 1 325 Скачать Далее
Remaining questions on the management of HER2-low breast cancer VJOncology 0:56 1 year ago 156 Скачать Далее
The evolution of HER2-low-positive breast cancer as a clinical subtype VJOncology 1:10 1 year ago 146 Скачать Далее
Clinical and molecular characteristics of HER2-low/zero early stage triple-negative breast cancer VJOncology 2:14 1 year ago 411 Скачать Далее
HER2-Low Breast Cancer: DESTINY or Good Science? Cancer Treatment Updates 11:12 6 months ago 15 642 Скачать Далее
HER2-low as a separate entity for defining HER2 BC and its prognostic and biological significance VJOncology 1:25 1 year ago 49 Скачать Далее
Overview of the management of HER2-low breast cancer patients ecancer 7:13 1 year ago 127 Скачать Далее
Trastuzumab Deruxtecan in HER2-Low Advanced Breast Cancer | NEJM NEJM Group 2:12 2 years ago 7 092 Скачать Далее
